Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

<h4>Background</h4> <p>Coronary artery bypass grafting (CABG) is the standard treatment for revascularization in patients with left main coronary artery (LMCA) disease, but use of percutaneous coronary intervention (PCI) for this indication is increasing. We compared PCI and CABG...

Full description

Bibliographic Details
Main Authors:	Mäkikallio, T, Holm, NR, Lindsay, M, Spence, MS, Erglis, A, Menown, IB, Trovik, T, Eskola, M, Romppanen, H, Kellerth, T, Ravkilde, J, Jensen, LO, Kalinauskas, G, Linder, RB, Pentikainen, M, Hervold, A, Banning, A, Zaman, A, Cotton, J, Eriksen, E, Margus, S, Sørensen, HT, Nielsen, PH, Niemelä, M, Kervinen, K, Lassen, JF, Maeng, M, Oldroyd, K, Berg, G, Walsh, SJ, Hanratty, CG, Kumsars, I, Stradins, P, Steigen, TK, Fröbert, O, Graham, AN, Endresen, PC, Corbascio, M, Kajander, O, Trivedi, U, Hartikainen, J, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, EH
Format:	Journal article
Language:	English
Published:	Elsevier 2016

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

Similar Items